Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Sam's Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company headquartered in Shijiazhuang, Hebei Province, specializing in the production of veterinary medicines and active pharmaceutical ingredients (APIs). The company offers a diverse range of products including antibiotics, anthelmintics, and nutritional supplements designed for the livestock and poultry industries. Hebei Sam's operates GMP-certified manufacturing facilities and maintains a strong focus on international trade, exporting its products to various regions worldwide. Their portfolio includes well-known generic compounds such as ivermectin, albendazole, and various tetracyclines. The firm plays a significant role in the animal health supply chain by providing cost-effective therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Sam's Pharmaceutical.